🇺🇸 FDA
Patent

US 12331079

Oncolytic virus platform to treat cancers with myxoma virus

granted A61KA61K2039/5154A61K2039/5256

Quick answer

US patent 12331079 (Oncolytic virus platform to treat cancers with myxoma virus) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5154, A61K2039/5256, A61K2039/545, A61K2039/572